Visceral obesity is strongly associated with insulin resistance. One potential cause is increased availability of FFA. Alternatively, it has been proposed that there is impaired oxidation of lipid in individuals at risk for obesity. The extent to which either concept involves skeletal muscle is uncertain. To examine these opposing hypotheses, 17 healthy lean and obese premenopausal women, among whom cross-sectional area of visceral fat ranged from 18 to 180 cm2, participated in leg balance studies for measurement of FFA and glucose utilization during basal and insulin-stimulated conditions. A metabolic profile of skeletal muscle, based on enzyme activity, was determined in vastus lateralis muscle obtained by percutaneous biopsy. Visceral fat content was negatively correlated with insulin sensitivity (rates of leg glucose uptake and storage), but insulin resistance was not caused by glucose-FFA competition. During hyperinsulinemia, neither leg FFA uptake nor oxidation was increased in women with visceral obesity. During fasting conditions, however, rates of FFA uptake across the leg were negatively correlated with visceral adiposity as were activities of muscle carnitine palmitoyl transferase and citrate synthase. In summary, visceral adiposity is clearly associated with skeletal muscle insulin resistance but this is not due to glucose-FFA substrate competition. Instead, women with visceral obesity have reduced postabsorptive FFA utilization by muscle. (J. Clin. Invest. 1995Invest. . 95:1846Invest. -1853.) Key words: visceral obesity insulin resistance * human skeletal muscle * free fatty acid metabolism * carnitine palmitoyl transferase
Introduction
Nearly one third of adults in the United States are overweight (1) . One phenotype of obesity, that characterized by increased visceral fat deposition, particularly increases risk for non-insulin-dependent diabetes mellitus, essential hypertension, and dyslipidemia (2) (3) (4) (5) . These associations have been attributed to insulin resistance. One potential cause of insulin resistance within skeletal muscle of individuals with visceral obesity is increased FFA utilization by muscle (6) . The role of glucose-FFA substrate competition in evoking insulin resistance in obe-sity has been supported by some, but not all, investigations of systemic glucose and FFA metabolism (7) (8) (9) . However, to our knowledge there has not been an investigation which has examined in vivo muscle FFA uptake in individuals with visceral obesity during simultaneous measurement of muscle insulin sensitivity.
In contrast to the hypothesis that FFA causes insulin resistance, other investigations suggest instead that lipid oxidation is impaired in individuals at risk for obesity (10, 11) . While the tissue(s) responsible for impaired fat oxidation has not been clearly identified, the recent finding that skeletal muscle lipoprotein lipase activity is decreased in association with increased systemic RQ (12) , and is diminished in individuals with visceral obesity (13) , suggests a defect of fat utilization by muscle. Among healthy, lean individuals there is efficient uptake and oxidation of plasma FFA in skeletal muscle during postabsorptive conditions (14, 15) . Whether this pattern is diminished in individuals with visceral obesity has not been determined previously.
This study was undertaken to test these two alternative and opposing hypotheses regarding the effects of visceral obesity upon substrate utilization by muscle. The first hypothesis is that glucose-FFA substrate competition contributes to insulin resistance of skeletal muscle in women with visceral obesity. This was tested by measuring simultaneous rates of FFA and glucose uptake by muscle, using leg balance methods, during insulin-stimulated conditions in lean and obese healthy premenopausal women. The second hypothesis is that muscle FFA utilization is diminished in women with visceral obesity during fasting conditions. To test this hypothesis, rates of leg FFA uptake were measured during basal conditions and vastus lateralis muscle was obtained by percutaneous biopsy for analysis of enzyme activities which have potential regulatory roles for glucose and FFA metabolism. The Body composition. Standing height, weight, minimal waist circumference, and maximum hip circumference were measured using standard methods (16) . Computed tomography (9800 scanner; General Electric, Milwaukee, WI) was used to measure intraabdominal adipose tissue using a 10-mm cross-sectional scan through the abdomen centered on the disc space between the fourth and fifth lumbar vertebrae (17) . At mid-thigh, a cross-sectional CT scan was obtained, and subcutaneous adipose area was measured electronically (18) ; for a separate protocol, muscle attenuation was also examined (19). Total body adiposity was estimated using a four-electrode bioelectrical impedance system (Bioelectric Sciences, Inc., La Jolla, CA) at the right wrist and ankle, as described previously (18 15 min after completion of the muscle biopsy, a 5-h euglycemic insulin infusion was started. For 3 h, insulin was infused at 10 mU/mini m2, followed by a 2-h insulin infusion at 40 mU/min/m2, to measure the effects of mild and moderate hyperinsulinemia on leg glucose and FFA utilization. Euglycemia was maintained using the glucose clamp method (22) , with a variable infusion of 20% dextrose, to which [3-3H] glucose (0.16 MCi/g dextrose) had been added to maintain stable plasma glucose specific activity (23) . During the final 30 min of each insulin infusion (i.e., 150-180 min, 270-300 min), arterial and venous sampling was carried out as described for the postabsorptive period.
Analysis. Plasma glucose was measured using a glucose oxidase system (model 23A; Yellow Springs Instrument Co., Yellow Springs, OH). Arterial and femoral venous blood 02 content was determined with a co-oximeter (IL282 co-oximeter system; Allied Instrument Laboratory, Lexington, MA). Plasma CO2 content was measured (system 1304 pH/blood gas analyzer; Allied Instrument Laboratory), and each blood gas analysis immediately followed blood sampling. Plasma CO2 content was later adjusted to blood CO2 content using a regression equation (24) , containing hemoglobin, saturation, and sample pH. To measure oleate radioactivity, plasma FFA were extracted according to the method of Dole and Meinertz (25) using 5 ml of extraction mixture. The procedure was modified according to Robin et al. (26) [3-3H] glucose was 0.2±0.1%. At the level of plasma glucose radioactivity attained in the current study (-2,000 dpm/ml), cross-over into organic extracts would have added -5-10 dpm per sample, a minor effect further negated since measurement of arteriovenous differences in FFA radioactivity was the main objective. Plasma [3-3H] glucose radioactivity was determined after deproteinization of plasma using barium hydroxide and zinc sulfate with evaporation of the aqueous extract (pH = 7.3) to dryness to remove tritiated water before liquid scintillation counting, as previously described (27) . Recovery of plasma glucose radioactivity was 84± 1.0%. Preliminary studies demonstrated negligible recovery of [9,10-3H]oleate (0.02±0.01%), within the aqueous extract of plasma obtained by deproteinization of plasma using the barium/zinc procedure. Plasma FFA was measured using a commercially available enzymatic spectrophotometric assay (NEFA-C; Wako Chemical Inc., Dallas, TX). Plasma glycerol was assayed by an enzymatic method (Triglyceride GPO-Trinder kit; Sigma Chemical Co., St. Louis, MO). Lactate and alanine were determined by enzymatic assays, and plasma insulin was determined by radioimmunoassay, as previously described (18) .
Muscle analyses. Adequate muscle samples were obtained at biopsy from 15 of the 17 subjects. Muscle samples were immediately frozen in liquid nitrogen and stored at -70°C until shipment in dry ice to the Physical Activity Sciences Laboratory at Laval University, for analysis by one of the investigators (J.-A. Simoneau), who was blinded as to the clinical status of each subject. One of the shipments, containing samples from 3 volunteers, was destroyed because of thawing during shipment, so muscle from only 12 subjects was available for analysis. The activity levels of creatine kinase (EC 2.7. (EC 2.7. (23) . Systemic rates of carbohydrate and lipid oxidation were calculated from values for gas exchange and urine urea nitrogen excretion using the equations of Frayn (32) , and these equations were adapted for indirect calorimetry across a limb, as previously described (20) , using empiric 1. Abbreviations used in this paper: BMI, body mass index; CPT, carnitine palmitoyl transferase; CS, citrate synthase; FFM, fat free mass; HADH, 3-hydroxyacyl CoA dehydrogenase. 
Results
Postabsorptive metabolism. During postabsorptive conditions, FFA uptake across the leg was negatively correlated with visceral fat content (r = -0.60, P = 0.01), as shown in Fig. 1 . Fasting rates of FFA uptake across the leg were not correlated with systemic fat mass, body mass index (BMI), or subcutaneous fat of either abdomen or thigh. Metabolic profiles of skeletal muscle, based on activities of seven enzymes, are shown in Table II . A strong negative correlation was found between activity of muscle CPT and visceral fat content (r = -0.76, P < 0.05), and CPT activity was positively correlated with postabsorptive rates of FFA uptake by muscle (r = 0.52, P < 0.05), as shown in Fig. 2 Fig. 3 , CS activity in skeletal muscle, a marker enzyme of mitochondrial content, was positively correlated with lipid oxidation across the leg during fasting conditions (r = 0.48, P = 0.06), and CS activity was negatively correlated with visceral obesity (r = -0.51, P < 0.05). Fasting rates of leg glucose oxidation were correlated with activity of muscle glycogen phosphorylase (r = 0.66, P < 0.05). Activity of other enzymes, including activities of HADH (a marker enzyme of mitochondrial fatty acid /-oxidation) and CPT, was not significantly correlated with basal rates of leg lipid oxidation. Mild hyperinsulinemia. 3 h of insulin infusion at 10 mU/ m2/min increased arterial insulin to a steady state level of 168+21 pM (P < 0.01). FFA uptake across the leg decreased from a fasting rate of 261±20 to 115 ± 12 nmol/min (P < 0.01), with significant suppression of FFA release by the leg (144+28 nmol/min), as well as glycerol release (111±34 nmol/min).
Glucose uptake across the leg increased during mild hyperinsulinemia to 420±110 nmol/min (P < 0.01), while rates for net release of lactate and alanine were unaffected (80±50 nmol/ min). Leg RQ did not change significantly during mild hyperinsulinemia (0.82±0.03), nor did rates of glucose oxidation (330±70 nmol/min) and rates of lipid oxidation across the leg (170±35 nmol/min). Compared with basal conditions, mild hyperinsulinemia suppressed muscle glycogenolysis (14±89 nmol/min, P < 0.05) as the increase in uptake of plasma glucose accounted for glucose oxidation and net release of lactate and alanine.
Systemically, mild hyperinsulinemia suppressed arterial FFA concentration (136±19 ,uM), systemic rate of appearance of FFA (2.68±0.28 4tmol/min/kg FFM), and systemic lipid oxidation (3.23+0.25 pmol/min/kg FFM) (all P < 0.01). Hepatic glucose production decreased from a fasting rate of There were no significant correlations found between visceral obesity and rates of FFA or glucose uptake across the leg during mild hyperinsulinemia, and rates of FFA uptake across the leg were not correlated with corresponding rates of leg glucose uptake. Visceral fat had a negative, though nonsignificant, correlation with rates of lipid oxidation across the leg during mild hyperinsulinemia (r = -0.42, P = 0.10). Suppression of systemic FFA flux during mild hyperinsulinemia tended to be less in women with visceral obesity, but this correlation did not achieve significance (r = -0.40, P = 0.10). Women with increased visceral fat content also had a lesser decrease in rates of leg FFA uptake as compared with basal conditions (r = -0.58, P < 0.05).
Moderate hyperinsulinemia. During the subsequent 2-h insulin infusion at 40 mU/min/m2, steady state arterial insulin concentration was 504±28 pM. FFA uptake across the leg during moderate hyperinsulinemia was 110±13 nmol/min, which was unchanged compared with mild hyperinsulinemia but less than during basal conditions (P < 0.01). Similarly, release of FFA across the leg (107+14 nmol/min) and of glycerol (117±40 nmol/min) were unchanged as compared with rates during mild hyperinsulinemia, but reduced compared with basal conditions (P < 0.01). Glucose uptake across the leg increased to 2,290±340 nmol/min (P < 0.01) and was positively correlated (r = 0.68, P < 0.01) with rates of systemic glucose utilization (47.5±3.8 amol/min/kg FFM). Net release of lactate and alanine across the leg did not change significantly (120±10 nmol/min). Leg RQ during moderate hyperinsulinemia did increase, to 0.90±0.03 (P < 0.05), with a significant decrease of lipid oxidation across the leg (108±27 nmol/min) and increased glucose oxidation (640±100 nmol/min, P < 0.05). Rates of glucose storage across the leg increased significantly compared with mild hyperinsulinemia, from 14±89 to 1,540+320 nmol/min (P < 0.01).
Rates of leg glucose storage during moderate hyperinsulinemia were negatively correlated with visceral obesity as shown in Fig. 4 . A similar negative relationship was found between systemic nonoxidative glucose utilization (25.6±3.3 4umol/min/ kg FFM) and visceral fat content (r = -0.59, P < 0.01), without additional significance if other measures of obesity are added to the multiple regression model. There was relatively little variation in FFA uptake during moderate hyperinsulinemia with respect to visceral fat content, and no correlation was found between rates of FFA uptake across the leg during moderate hyperinsulinemia and simultaneous rates of leg glucose storage, as shown in Fig. 4 . Also, neither leg glucose storage nor uptake had a significant correlation with lipid oxidation by leg tissue during moderate hyperinsulinemia (both P > 0.2).
Other indices of obesity also had significant simple correlations with leg glucose storage and with systemic nonoxidative glucose utilization. However, in a multiple regression model containing five markers of obesity (visceral fat content, systemic fat mass, BMI, and subcutaneous areas of both thigh and abdominal fat), visceral obesity was the most powerful predictor of insulin resistance (i.e., rates of insulin-stimulated leg glucose storage), and each of the other measures did not retain independent significance. If other measures of adiposity are initially forced into the regression model, visceral obesity still retained independent significance. There were two other metabolic markers found for insulin sensitivity of skeletal muscle. Insulin-stimulated glucose storage by muscle was increased in women with higher rates of postabsorptive lipid oxidation across the leg (r = 0.61, P < 0.05). Using a multiple regression model, increased visceral fat (r = -0.63, P < 0.01) and reduced basal leg FFA oxidation (r = 0.61, P < 0.01) each contributed significantly in predicting insulin resistance (r2 = 0.56, P < 0.01). The other marker of insulin sensitivity was activity of muscle CS, which had a positive correlation with leg glucose uptake during moderate hyperinsulinemia (r = 0.66, P < 0.05).
During moderate hyperinsulinemia, arterial FFA concentration decreased to 94±12 ,uM, systemic FFA rate of appearance decreased to 2.18±0.23 ,umol/min/kg FFM, and systemic lipid oxidation also decreased (to 1.70+0.26 umol/min/kg FFM), each P < 0.01. Systemic glucose oxidation increased to 21.9±1.3 1tmol/min/kg FFM. None of these systemic parameters were correlated with visceral fat content.
Discussion
One of the metabolic complications of visceral obesity is insulin resistance. The mechanism which accounts for the association Obese women with upper body fat distribution have been found to have increased flux of FFA (7, 34) , and it has been suggested that insulin resistance of skeletal muscle could derive in part from glucose-FFA substrate competition (6). (12) , which suggests strongly that muscle is an important tissue contributing to impaired lipid oxidation. A negative correlation between waist to hip ratio and muscle lipoprotein lipase activity has been reported ( 12) . In classic studies, Zierler and colleagues (14, 15) demonstrated that lipid oxidation normally predominates in skeletal muscle during postabsorptive conditions in association with high rates of FFA uptake across the limb. These findings were reconfirmed in the current study among lean healthy women. However, the current study indicates that FFA utilization by muscle during postabsorptive conditions is perturbed among women with increased visceral fat content. Additionally, visceral fat and insulin resistance were linked to enhanced glycolytic and reduced oxidative enzyme activities in muscle (19).
This study further suggests that a heightened capacity for muscle FFA utilization during fasting conditions is linked to insulin sensitivity. A positive relationship was found between fasting rates of FFA oxidation across the leg and rates of insulinstimulated glucose storage by muscle. Women with increased muscle CS activity had higher postabsorptive rates of muscle FFA utilization as well as increased insulin-stimulated muscle glucose storage. In contrast, women with visceral obesity had reduced fasting uptake of FFA by muscle, skeletal muscle insulin resistance, and lower activity of CS in muscle. This enzyme catalyzes formation of citrate from acetyl CoA, the latter representing the biochemical convergence of FFA and glucose metabolism within the mitochondria (36) . CS is a key enzymatic marker of muscle mitochondrial content and of overall aerobicoxidative potential of muscle (38) . The finding that both fasting FFA metabolism and insulin-stimulated glucose metabolism are correlated with activity of CS suggests that regulation of postabsorptive use of FFA by muscle is integrally linked to phenotypic expression of insulin sensitivity. This concept has been suggested previously by the positive relationship between fasting activity of muscle lipoprotein lipase and insulin sensitivity (39) , and more broadly by the findings that exercise, which potently enhances insulin sensitivity of muscle, concomitantly increases the capacity of muscle for lipid utilization (40) .
Visceral obesity is one component of a syndrome which includes glucose intolerance, essential hypertension, and dyslipidemia, with the common linkage thought to be insulin resistance (2) (3) (4) (5) . Therefore, the question arises as to what extent do abnormalities of FFA utilization by muscle arise secondarily to glucose intolerance, dyslipidemia, or hypertension. Several recent studies from our laboratory indicate that hyperglycemia impairs muscle FFA utilization, and more specifically lipid oxidation, during fasting conditions (41, 42) . The current study indicates, however, that the abnormality of muscle FFA utilization associated with visceral obesity is not solely occurring secondarily to other components of the insulin resistance syndrome. The premenopausal women participating in this study were carefully screened to exclude individuals with hypertension, glucose intolerance, or dyslipidemia.
Whether visceral obesity develops as a consequence of impaired lipid utilization by muscle, or vice versa, is not resolved by the correlative relationships revealed in the current study, and this issue will require further research. Among the adverse effects to which impaired FFA utilization by muscle could contribute is potential diversion of FPA toward increased synthesis of triglyceride, either for lipoprotein synthesis in the liver or for fat storage in other tissues (5). Campbell et al. (43) have found that reesterification of FFA is increased in obesity. Impaired capacity for lipid oxidation by muscle could favor partitioning FFA toward triglyceride deposition within muscle itself, and triglyceride content of muscle is a powerful marker of insulin resistance (44).
In this study, among several measures of adiposity, visceral fat content as determined by computed tomography emerged as the strongest correlate with insulin resistance and other parameters of muscle metabolism. This is generally consistent with previous findings (45) , but more information is needed to assess whether it is relative fat distribution, absolute amounts of visceral fat, or general corpulence which is of greatest importance for impaired muscle FEA and glucose metabolism. In a series of elegant studies, Jensen and colleagues have found that obese women with increased waist to hip ratio have insulin resistance in regulation of lipolysis (7, 34) . We did not find a significant effect of visceral obesity on insulin regulation of lipolysis but it is likely that the differences between our results and those of Martin and Jensen (34) may be that the level of mild hyperinsulinemia in the current study was twofold higher than that studied by Martin and Jensen. Because of pronounced effects of insulin upon lipolysis (46) , the higher insulin levels in the current study may have obscured potential differences among our subjects. However, with regard to the effects of mild hyperinsulinemia on muscle glucose metabolism, the primary effect which was found was suppression of glycogenolysis, and this is consistent with recent studies by Rossetti and Hu (47) .
In summary, this study reconfirms the strong link between visceral obesity and skeletal muscle insulin resistance. The data on rates of FFA uptake across the leg during insulin infusion fail to support the hypothesis that glucose-FFA substrate competition is a cause of insulin resistance in visceral obesity. However, there were important new findings regarding rates of FFA uptake by muscle during fasting conditions, which in conjunction with determinations of muscle CPIT and CS activities, indicate that the presence of visceral obesity is associated with diminished capacity for postabsorptive utilization of plasma FFA by skeletal muscle.
